Device component company Presspart Manufacturing has announced that former Lupin pulmonary research scientist Abhay Singh and former Sanofi QC readiness analyst Jacqueline Green have joined Presspart's Inhalation Product Technology Centre (IPTC) team. Singh has been hired as Senior Analyst, Green as Research Analyst. In late 2012, Presspart announced that it had … [Read more...] about Presspart adds two to its Inhalation Product Technology Centre team
People
OptiNose announces senior management additions
OptiNose has announced three hires for senior management positions, which it says "will help drive the company forward in its mission to introduce new and valuable treatment options to the market utilizing its novel Bi-Directional Breath Powered Delivery Technology." The company has hired Ramona Lloyd as VP, Regulatory Affairs & Quality; Sheila Bergey as VP, … [Read more...] about OptiNose announces senior management additions
Parion announces management changes
Parion Sciences, which is developing a trans-nasal aerosol delivery system and several products for cystic fibrosis, has announced several changes to its executive team. Paul Boucher, previously VP of Finance & Business has been promoted to President; Joe Schachle, previously Head of Global Marketing Operations at Grifols, has been hired as Chief Operating Officer; … [Read more...] about Parion announces management changes
Retrophin names new President/COO and Executive VP of R&D
Retrophin, which is developing Syntocinon intranasal oxytocin, has named Stephen Aselage as President and Chief Operations Officer and Alvin Shih as Executive VP of Research and Development. Aselage, who has stepped down as CEO, was Executive VP and Chief Business Officer at BioMarin Pharmaceutical before joining Retrophin in 2012, and Shih is currently COO of … [Read more...] about Retrophin names new President/COO and Executive VP of R&D
Insmed adds former AstraZeneca CEO to its board
Arikayce inhaled liposomal amikacin developer Insmed has announced that former AstraZeneca CEO David R. Brennan will join the company's board of directors. Insmed Chairman of the Board Donald J. Hayden commented, "We are delighted to welcome David to the Insmed Board. David's deep and diverse set of global operating experiences will be invaluable as we build … [Read more...] about Insmed adds former AstraZeneca CEO to its board
Discovery Labs announces two hires to oversee Aerosurf development
Discovery Laboratories has hired former AstraZeneca Senior Medical Director Steve Simonson as VP, Clinical Development and former PARI VP and Director of Product Technology Lawrence Weinstein as VP, Medical Device Development, the company said. The new hires, both of whom have extensive OINDP experience, will oversee development of the Aerosurf aerosolized KL4 … [Read more...] about Discovery Labs announces two hires to oversee Aerosurf development
2014 Charles G. Thiel award presented to Dieter Hochrainer of Boehringer Ingelheim
The organizers of RDD 2014 have announced that the 2014 winner of the Charles G. Thiel Award is Dieter Hochrainer of Boehringer Ingelheim. The award was presented by Peter Byron at the opening of the conference, which is taking place in Fajardo, Puerto Rico. The award, sponsored by 3M Drug Delivery Systems and an endowment at Virginia Commonwealth University, is … [Read more...] about 2014 Charles G. Thiel award presented to Dieter Hochrainer of Boehringer Ingelheim
Alexza hires Winston R. Brown, Jr. as VP, Quality
Alexza Pharmaceuticals has hired Winston R. Brown, Jr. as VP, Quality, the company has announced. Brown was most recently Global Head, Quality R&D - Pharmaceuticals, Biologics, and Vision Care Devices at Alcon Research. The company has made several hires recently as it is in the process of commercializing its Adasuve inhaled loxapine for the treatment of … [Read more...] about Alexza hires Winston R. Brown, Jr. as VP, Quality
Molecular Profiles looks to increase US business
CDMO Molecular Profiles says that it has hired Charles D. Maher as head of US sales in order to "increase awareness and uptake of its pharmaceutical development services in the North American market." The company's services include formulation development and clinical trial manufacturing of dry powder inhalers. Molecular Profiles CEO Nikin Patel commented, "Over … [Read more...] about Molecular Profiles looks to increase US business
Insmed announces management changes
In anticipation of the potential commercialization of its Arikayce inhaled liposomal amikacin, Insmed has announced a number of management changes designed to "better align the organization with the company's growth opportunities." Those changes are: Renu Gupta, currently Executive VP of Development and Chief Medical Officer, will become Special Advisor to the … [Read more...] about Insmed announces management changes